Robert D. Junkins

A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1–insensitive models of triple-negative breast cancer

Ning Cheng, Rebekah Watkins-Schulz, Robert D. Junkins et al. · JCI Insight · 2018 · 252 citations · Full text

Medicine, Immunology, Oncology +17

A noncanonical function of cGAMP in inflammasome priming and activation

Karen V. Swanson, Robert D. Junkins, Cathryn J. Kurkjian et al. · The Journal of Experimental Medicine · 2017 · 153 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination

Robert D. Junkins, Matthew D. Gallovic, Brandon M. Johnson et al. · Journal of Controlled Release · 2017 · 151 citations

Pharmacy, Immunology, Molecular Pharmaceutics +16

Autophagy Enhances Bacterial Clearance during P. aeruginosa Lung Infection

Robert D. Junkins, Ann Shen, Kirill V. Rosen et al. · PLoS ONE · 2013 · 91 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

A microparticle platform for STING-targeted immunotherapy enhances natural killer cell- and CD8+ T cell-mediated anti-tumor immunity

Rebekah Watkins-Schulz, Pamela Tiet, Matthew D. Gallovic et al. · Biomaterials · 2019 · 89 citations · Full text

Life Sciences, Immunology, Oncology +17